MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much ...

Chimeric antigen receptor-T (CAR-T) cell therapy represents a major breakthrough in cancer immunotherapy, providing remarkable clinical benefits for ...

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's defense systems, according to a study led by investigators at Weill Cornell ...

A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ...

Researchers at Weill Cornell Medicine have discovered that activated T cells release extracellular vesicles carrying immune-related DNA fragments that can enter both immune and tumor cells, enhancing ...